Microbot Medical Inc (MBOT) Stock Price, Quote & News

Company Profile

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual propert...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 781 875 3605

Website: microbotmedical.com

Address:

175 Derby Street, Bld. 27, Hingham, United States

Samtosemi May. 20 at 3:10 AM

$MBOT "Because it's a portable, small, under capital budget device it was like asking for another catheter. It's nice no barriers financial or otherwise" This is a very underrated quote because they uncovered Mbot is actually extremely affordable in addition to the White diamond Report being directly contradicted by the very Surgeon they tried to quote across the board on every problem they tried to raise. Both surgeons were saying the hospitals are enouraging the use of liberty and it seems from what they were saying it's cheap and possibly even classified as a supply instead of equipment. Either way we are now getting an idea of Liberty being an easy sell at its price range.

2 · Reply

dubovmm May. 19 at 7:26 PM

$MBOT Remember WDR: Dr. Charles Briggs (Vascular Surgeon at Tampa General Hospital) and Dr. Zachary Bercu (Interventional Radiologist at Emory Healthcare) Clinician Testimonials: Executive management was joined by physicians currently using the LIBERTY system—Dr. Charles Briggs (Vascular Surgeon at Tampa General Hospital) and Dr. Zachary Bercu (Interventional Radiologist at Emory Healthcare). They shared their real-world clinical experience and categorically disputed statements falsely attributed to them in the third-party piece.

0 · Reply

Growinspace May. 19 at 5:09 PM

$MBOT Right, MBOT is a "Diamond " in the rough, it'll be $10 before you know it, hang on eddy, mgmt has this under control, they know exactly what they're doing, the pace they set, the interest and demand is there, it's all coming together

1 · Reply

Eddypgil May. 19 at 4:29 PM

$MBOT white diamond report has merit

1 · Reply

WalmaCiardo May. 19 at 4:06 PM

$MBOT What did you take from the call? Lets discuss

2 · Reply

gladee88er May. 19 at 4:04 PM

$MBOT What was that? Another drop for ants?

0 · Reply

Growinspace May. 19 at 2:25 PM

$MBOT Sad, the shorts are winning for now, But, not for long, it'll catch fire and go north, back to $2+, hold tight, too many positive things happening, it would be nice for for company to announce or share Some success stories to slow the pain , still Bullish n

2 · Reply

Eddypgil May. 19 at 1:41 PM

$MBOT

0 · Reply

MisterNessuno May. 19 at 1:19 PM

$MBOT i see in this story the same about Gorilla technology

0 · Reply

Eddypgil May. 19 at 12:00 PM

$MBOT not convincing

1 · Reply

Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu

May 14, 2026, 8:30 AM EDT - 5 days ago

Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026

May 5, 2026, 8:30 AM EDT - 14 days ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

Apr 30, 2026, 8:30 AM EDT - 19 days ago

Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)

Apr 22, 2026, 8:30 AM EDT - 27 days ago

Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®

Apr 14, 2026, 2:30 PM EDT - 5 weeks ago

Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference

2026-04-13T13:42:46.000Z - 5 weeks ago

Microbot Medical begins full market release of LIBERTY endovascular system

Apr 13, 2026, 8:30 AM EDT - 5 weeks ago

Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting

Mar 26, 2026, 8:30 AM EDT - 7 weeks ago

Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®'s LIBERTY® Endovascular Robotic System

2026-03-24T13:20:14.000Z - 2 months ago

Microbot Medical announces publication of ACCESS PVI pivotal study results

Mar 24, 2026, 8:30 AM EDT - 2 months ago

Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal

Mar 17, 2026, 8:40 AM EDT - 2 months ago

Microbot Medical® to Participate at the 38th Annual Roth Conference

Mar 10, 2026, 8:30 AM EDT - 2 months ago

Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time

2026-03-04T13:47:25.000Z - 2 months ago

Microbot ‘commends’ AMA for efforts to protect workers from ionizing radiation

Mar 4, 2026, 8:30 AM EST - 2 months ago

Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation

2026-03-03T14:12:31.000Z - 2 months ago

Microbot Medical confirms continued operational, commercial stability

Mar 3, 2026, 9:00 AM EST - 2 months ago

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event

2026-02-24T13:42:13.000Z - 3 months ago

Microbot Medical announces Tampa General Hospital adopted LIBERTY

Feb 24, 2026, 8:30 AM EST - 3 months ago

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

2026-02-19T13:38:29.000Z - 3 months ago

Microbot Medical’s Liberty Endovascular Robotic System continues to expand

Feb 19, 2026, 8:30 AM EST - 3 months ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference

2026-02-12T13:42:27.000Z - 3 months ago

Microbot Medical’s LIBERTY system highlighted at ISET conference

Feb 12, 2026, 8:30 AM EST - 3 months ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

2026-02-10T10:15:10.000Z - 3 months ago

Microbot Medical initiated with a Buy at B. Riley

2026-02-05T13:42:01.000Z - 3 months ago

Microbot Medical to share insights, experiences of Liberty system at SIO

Feb 5, 2026, 8:30 AM EST - 3 months ago

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

2026-01-12T13:55:44.000Z - 4 months ago

Microbot Medical announces key 2026 milestones

Jan 12, 2026, 8:30 AM EST - 4 months ago

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

2025-12-03T09:25:07.000Z - 5 months ago

Microbot Medical initiated with a Buy at Roth Capital

2025-11-26T13:35:43.000Z - 6 months ago

Microbot Medical announces Emory University first hospital to adopt LIBERTY

Nov 26, 2025, 8:30 AM EST - 6 months ago

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

2025-11-05T13:35:26.000Z - 6 months ago

Microbot Medical commences LMR of its LIBERTY system in the U.S.

Nov 5, 2025, 8:30 AM EST - 6 months ago

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

2025-10-16T12:46:19.000Z - 7 months ago

Microbot Medical to commercially debut LIBERTY System at Symposium

Oct 16, 2025, 8:30 AM EDT - 7 months ago

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

2025-10-14T12:35:57.000Z - 7 months ago

Microbot Medical partners with 3PL company to commercialize LIBERTY System

Oct 14, 2025, 8:30 AM EDT - 7 months ago

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

2025-10-14T10:36:54.000Z - 7 months ago

Microbot Medical files to sell 900,153 shares of common stock for holders

2025-10-14T10:36:43.000Z - 7 months ago

Microbot Medical files to sell 14.69M shares of common stock for holders

2025-10-07T12:20:41.000Z - 8 months ago

Microbot Medical closes exercise of outstanding preferred investment options

Oct 7, 2025, 8:00 AM EDT - 8 months ago

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

2025-10-01T13:06:02.000Z - 8 months ago

Microbot Medical receives first patent in Japan, covering LIBERTY System

Oct 1, 2025, 9:00 AM EDT - 8 months ago

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Sep 23, 2025, 8:30 AM EDT - 8 months ago

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Sep 16, 2025, 3:37 PM EDT - 8 months ago

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

2025-09-15T12:11:22.000Z - 8 months ago

Microbot Medical announces exercise of outstanding preferred investment options

Sep 15, 2025, 8:00 AM EDT - 8 months ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

Sep 9, 2025, 8:28 AM EDT - 9 months ago

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Sep 8, 2025, 8:28 AM EDT - 9 months ago

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Aug 20, 2025, 8:30 AM EDT - 9 months ago

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Jul 22, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Jul 8, 2025, 8:30 AM EDT - 11 months ago

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Jun 30, 2025, 8:30 AM EDT - 11 months ago

Microbot Medical® Added to the Russell Microcap® Index

Jun 17, 2025, 8:30 AM EDT - 1 year ago

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Jun 9, 2025, 8:30 AM EDT - 1 year ago

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Jun 5, 2025, 8:30 AM EDT - 1 year ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Apr 23, 2025, 8:30 AM EDT - 1 year ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Apr 9, 2025, 8:30 AM EDT - 1 year ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Apr 1, 2025, 8:30 AM EDT - 1 year ago

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Mar 4, 2025, 8:30 AM EST - 1 year ago

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Feb 25, 2025, 8:30 AM EST - 1 year ago

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Feb 11, 2025, 6:15 PM EST - 1 year ago

Microbot Medical Closes $13 Million Registered Direct Offering

Feb 10, 2025, 8:00 AM EST - 1 year ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jan 10, 2025, 10:25 AM EST - 1 year ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 7, 2025, 4:15 PM EST - 1 year ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Dec 30, 2024, 8:30 AM EST - 1 year ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 10, 2024, 10:18 AM EST - 1 year ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Oct 15, 2024, 8:38 AM EDT - 1 year ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Sep 30, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Samtosemi May. 20 at 3:10 AM

2 · Reply

dubovmm May. 19 at 7:26 PM

0 · Reply

Growinspace May. 19 at 5:09 PM

1 · Reply

Eddypgil May. 19 at 4:29 PM

$MBOT white diamond report has merit

1 · Reply

WalmaCiardo May. 19 at 4:06 PM

$MBOT What did you take from the call? Lets discuss

2 · Reply

gladee88er May. 19 at 4:04 PM

$MBOT What was that? Another drop for ants?

0 · Reply

Growinspace May. 19 at 2:25 PM

2 · Reply

Eddypgil May. 19 at 1:41 PM

$MBOT

0 · Reply

MisterNessuno May. 19 at 1:19 PM

$MBOT i see in this story the same about Gorilla technology

0 · Reply

Eddypgil May. 19 at 12:00 PM

$MBOT not convincing

1 · Reply

Hpkmd01 May. 19 at 11:14 AM

$MBOT Time for a different kind of reporting.

1 · Reply

m0bley May. 19 at 11:01 AM

$MBOT This. The key points the whitediamond tried to stand on were calmly, confidently, and without hyperbole, refuted.

0 · Reply

Lordlittle May. 19 at 7:16 AM

$MBOT we found a white diamond employee upset that his fake shit been ruined 😂

1 · Reply

Readcarefully May. 19 at 5:32 AM

$MBOT This will be worth buying after they have executed at least a $300M offering. Because they will continue to lose money for at least the next 12 quarters.

3 · Reply

NoItWasntMe May. 19 at 2:08 AM

$MBOT Regarding LIBERTY VS the manual approach, LIBERTY saves the surgeon from having to stand over the patient for many minutes, up to 2-3 hours. Imagine doing that more than once a day. Not fun. Liberty allows them to take a seat in a shielded area nearby. For the really skilled surgeons who enjoy navigating challenging routes, hey if they want to be mavericks, let them. IMO the “easy button” is clearly LIBERTY. I have no idea why a younger/newer surgeon would choose the old school harmful way (harmful to their health) VS the new LIBERTY way. Protect the surgeon’s back and health. Notice, I am not even mentioning the heavy protective vest. That only magnifies the issues for the surgeon.

0 · Reply

NoItWasntMe May. 19 at 1:17 AM

$MBOT When the “research” folks make a “strong argument”, they need to be correct ON ALL POINTS. A few holes were pierced in their logic and factual details, throwing their entire argument much further into doubt. Eg .014” is NOT the only option as the report writers would have us believe. Radiation IS actually an issue. LIBERTY does NOT prolong procedure time. Pricing is not an issue, it is even in line with some existing catheters AND seems to be relatively trivial for hospital admins to approve. Why believe anything else they write when they were so off on these findings and much more? In all, nothing has changed except for the stock price since before the “research report”.

0 · Reply

NoItWasntMe May. 19 at 1:11 AM

$MBOT other than painful connection difficulties, it was a somewhat good call. Less rehash of already released PRs and more direct rebuttal would have been great. However, I do agree with another poster, the docs did well. IMO LIBERTY is best for: -difficult cases where routes are challenging, especially for newer docs -hospitals that don’t want to use a larger robot for peripheral endo procedures, when a disposable option is faster wrto setup and sterilization and not a capital intensive acquisition. -smaller centers that don’t have an existing robot but would like to offer the same service, which provides a high level of accuracy.

1 · Reply

Lordlittle May. 18 at 10:26 PM

$MBOT please don’t jump up yet just 4 more days till pay day 😭😭

0 · Reply

Eddypgil May. 18 at 9:15 PM

$MBOT what is White Diamonds price target?

2 · Reply

StocksGoddess May. 18 at 8:37 PM

$MBOT White Diamond Research is a scum, its head is Adam Gefvert, a disgusting bald scammer, his X account is Shiningboy https://x.com/Shiningboy Send him your message in X.

0 · Reply

ImCrazy May. 18 at 8:18 PM

$MBOT Good call! Still here

0 · Reply

Glider365 May. 18 at 8:06 PM

$MBOT I just find it really annoying how a scam fake news article does so much damage but an amazing call refuting the entire article doesn't help the price at all. Long term it's not an issue I just hate it.

3 · Reply

Market Cap	119.55M
Revenue (ttm)	0.00
Net Income (ttm)	-13.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.01

Volume	2,261,600
Avg Vol	1,756,228
Day's Range	N/A - N/A
Shares Out	67.17M
Stochastic %K	12%
Beta	1.06
Analysts	Strong Sell
Price Target	$8.50